TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8311
+0.0012 (0.14%)
Mar 24, 2026, 1:56 PM EDT - Market open

TELA Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-39-37.84-46.66-44.3-33.28-28.79
Depreciation & Amortization
1.051.010.811.190.540.53
Stock-Based Compensation
4.074.365.033.993.662.06
Other Adjustments
3.6-4.291.644.142.121.84
Change in Receivables
-0.06-0.76-3.06-2.42-1.550.15
Changes in Inventories
-0.84-2.97-2.72-6.07-5.19-0.62
Changes in Accounts Payable
0.050.480.01-0.881.4-2
Changes in Accrued Expenses
0.26-1.814.182.42.672.32
Changes in Other Operating Activities
-0.010.23-0.081.22-0.990.07
Operating Cash Flow
-30.88-41.6-40.86-40.75-30.43-24.46
Capital Expenditures
-0.62-0.99-0.61-0.87-0.63-0.17
Sale of Property, Plant & Equipment
--0.01---
Purchases of Intangible Assets
----1--
Proceeds from Sale of Investments
-----9.29
Proceeds from Business Divestments
1.095.44----
Investing Cash Flow
0.464.45-0.6-1.87-0.639.12
Long-Term Debt Issued
---40--
Long-Term Debt Repaid
----30--
Net Long-Term Debt Issued (Repaid)
---10--
Issuance of Common Stock
0.243.4346.5634.470.5944.93
Repurchase of Common Stock
-0.21-0.37-0.29-0.16--
Net Common Stock Issued (Repurchased)
-0.0243.0646.2734.310.5944.93
Other Financing Activities
----3.46--0.52
Financing Cash Flow
42.8143.0646.2740.850.5944.41
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.030.16-0.140.010.02
Net Cash Flow
12.45.944.98-1.91-30.4629.09
Free Cash Flow
-31.5-42.58-41.47-41.62-31.06-24.62
FCF Margin
-40.88%-61.45%-70.94%-100.49%-105.42%-135.19%
Free Cash Flow Per Share
-0.72-1.49-1.81-2.56-2.15-1.90
Levered Free Cash Flow
-39.12-41.89-45.08-37.32-35.48-28.67
Unlevered Free Cash Flow
-35.53-38.03-42.49-42.03-31.66-25.15
Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q